The mortality rate for ovary malignant neoplasms in Japan shows a slight upward trend from 2024 to 2028, with values increasing from 7.6 to 7.7 deaths per 100,000 women. The year-on-year variation between 2024 and 2025 is stable at zero percent, while between 2026 and 2027 an increase of approximately 1.3% is observed. The compound annual growth rate (CAGR) over this five-year period is minimal, indicating a relatively steady mortality rate.
Future trends to watch for include advancements in medical technology and early detection methods, which may impact future mortality rates. Moreover, demographic changes and healthcare policy adjustments could further influence these figures.
